Package 73190-052-30

Brand: deferasirox

Generic: deferasirox
NDC Package

Package Facts

Identity

Package NDC 73190-052-30
Digits Only 7319005230
Product NDC 73190-052
Product ID 73190-052_485c4f9f-883c-2579-e063-6294a90adbfe
Description

30 TABLET in 1 BOTTLE (73190-052-30)

Marketing

Marketing Status
Marketed Since 2026-01-14
Brand deferasirox
Generic deferasirox
Sample Package No

Linked Drug Pages (1)

Deferasirox ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "485c4f9f-883c-2579-e063-6294a90adbfe", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "unii": ["V8G4MOF2V9"], "rxcui": ["1607792"], "spl_set_id": ["485c4834-7bec-2018-e063-6294a90ab4e3"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["AvKARE"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (73190-052-30)", "package_ndc": "73190-052-30", "marketing_start_date": "20260114"}], "brand_name": "Deferasirox", "product_id": "73190-052_485c4f9f-883c-2579-e063-6294a90adbfe", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "73190-052", "generic_name": "Deferasirox", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferasirox", "active_ingredients": [{"name": "DEFERASIROX", "strength": "360 mg/1"}], "application_number": "ANDA210945", "marketing_category": "ANDA", "marketing_start_date": "20260114", "listing_expiration_date": "20271231"}